2016-04-15 |
133 |
|
Final Infringement Contentions for U.S. Patent Nos. 8,450,338 and 8,481,083 filed by Ferring International…20 February 2015
1:15-cv-00173-RGA
Patent
None
District Court, D. Delaware |
External link to document |
2016-05-31 |
142 |
|
Final Infringement Contentions for U.S. Patent Nos. 8,450,338 and 8,481,083 filed by Ferring International…20 February 2015
1:15-cv-00173-RGA
Patent
None
District Court, D. Delaware |
External link to document |
2016-06-01 |
143 |
|
Final Invalidity Contentions for U. S. Patent Nos. 8,450,338 and 8,481,083 filed by Par Pharmaceutical…20 February 2015
1:15-cv-00173-RGA
Patent
None
District Court, D. Delaware |
External link to document |
2017-07-11 |
192 |
|
this
ANDA infringes U.S. Patent Nos. 8,450,338 ("the '338 patent") and 8,481,083 ("…the '338 and '083 patents.
I. LEGAL STANDARDS
A patent is infringed when a person… sells
any patented invention, within the United States ... during the term of the patent, ... "…#39;338 PATENTS
Plaintiffs assert claims 1, 4-6, 8, 9-12, and 17-18 of the '338 patent and claims…#39;338 patent, then all limitations of the asserted dependent claims of
the '338 patent are met. |
External link to document |
2018-12-20 |
221 |
|
Abbreviated New Drug Application infringed U.S. Patent Nos. 8,450,338 and
8,481,083. (Id). Defendant filed its…2015
28 July 2017
1:15-cv-00173-RGA
Patent
None
District Court, D. Delaware |
External link to document |
2015-06-11 |
36 |
|
Initial Infringement Contentions for U.S. Patent Nos. 8,450,338 and 8,481,083 filed by Ferring International…20 February 2015
1:15-cv-00173-RGA
Patent
None
District Court, D. Delaware |
External link to document |